How Does SodaTide Work? The Mechanism, Step By Step

Most supplement mechanisms are inferred. This one has been isolated and tested, which is unusual enough to be worth a section of its own.

Chambers and colleagues built an inulin-propionate ester — a molecule that carries propionate past the small intestine and releases it in the colon, delivering roughly ten times the propionate that fermenting the inulin alone would. Sixty overweight adults took 10 g a day of either the ester or plain inulin for twenty-four weeks. The ester group gained less weight, had less intra-abdominal adipose tissue and less liver fat, and did not show the deterioration in insulin sensitivity the inulin control group did.

The control arm is the important half. Both groups received inulin; only one received extra colonic propionate. So the result is not 'fibre is good' — it is evidence that the short-chain fatty acid itself is doing the work, at a delivered quantity that ordinary fermentation of 10 g of inulin does not reach.

A later crossover in twelve adults compared the same ester at 20 g a day against inulin and against a low-fermentable control, and found both the ester and the inulin improved insulin sensitivity — with different effects on the microbiota, the plasma metabolome and inflammatory markers. Two routes to a similar endpoint, by different roads.

Two ideas are in play and they are not the same. The first is that adding live organisms changes the composition of the colony, so the same substrate ferments differently. The second is that particular organisms have effects of their own, independent of what they are fed.

The second is where the named-strain trials sit. SBT2055 reduced visceral fat area in a twelve-week trial; the dose-finding follow-up showed it worked at lower concentrations too. A meta-analysis across fifteen trials found small effects on body weight and fat percentage from mixed probiotics. A review restricted to Lactobacillus found species-level differences: some reduced body fat, some did not, and one was associated with weight gain.

None of that transfers to an unnamed blend. A trial result belongs to a strain the way a drug result belongs to a molecule, and 'probiotic blend' is not a molecule. That is the honest position and it is the position this site takes on every page that touches the subject.

• That the capsule holds enough inulin and resistant starch to be fermented in a quantity that matters. The lowest published bifidogenic dose is 5 g a day.
• That the probiotic strains are ones with evidence behind them, at a count high enough to survive the stomach. The label names neither.
• That the combination is at least additive. No trial has tested this particular combination, and none is likely to.
• That the user takes it for long enough. The fastest measured outcome in this literature is four weeks, and body composition takes sixteen.
• That the user's baseline fibre intake is low enough for a small addition to register. Somebody already eating beans and wholegrains daily has less headroom.

Three of those five are answerable by the buyer. Two are answerable only by the manufacturer, and the manufacturer has not answered them on the pack. That is the shape of this product: a defensible mechanism, an undisclosed quantity, and a 60-day window in which to find out what happens anyway.